ESMO 2022 Highlights

ESMO 2024 Kidney Cancer HighlightsПодробнее

Mercoledì dell'Oncologia | Highlights da ESMO 2024Подробнее

Research Highlights from ESMO Congress 2022, with David Ilson, MD, PhD, FASCO, Sumanta Pal, MD, F...Подробнее

ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc BrothersПодробнее

ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology BrothersПодробнее

ESMO 2023 highlights: advances in EGFR+ lung cancer second-line therapyПодробнее

Highlights in gynecological cancers at ESMO 2023Подробнее

8. ESMO 2022 HighlightsПодробнее

7. ESMO 2022 HighlightsПодробнее

ESMO 2023 HighlightsПодробнее

Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore studyПодробнее

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2Подробнее

Highlights on sotorasib plus panitumumab in KRAS G12C-mutated mCRC: The CodeBreak 300 studyПодробнее

【Teaser Trailer】Highlights on ESMO 2023 BREAST CANCER & Opinions of EurAsia oncology center expertsПодробнее

ESMO Sarcoma and Rare Cancers 2023 highlights: rare cancers at the forefrontПодробнее

Key highlights from ESMO Sarcoma and Rare Cancers 2023Подробнее

Highlights from ESMO TAT 2023 from Elena Garralda CabanasПодробнее

Highlights from ESMO Asia 2022 in HCCПодробнее

ESMO Asia 2022: Importance of successful collaboration to improve guidelines around the worldПодробнее

Sarcoma Academy: Multidisciplinary Highlights from ASCO ESMO CTOS in 2022 (08.12.2022)Подробнее